Rapid quantitation of lamivudine-resistant mutants in lamivudine treated and untreated patients with chronic hepatitis B virus infection.

[1]  Zhi-Jun Yang,et al.  Detection of YMDD mutants using universal template real-time PCR. , 2006, World journal of gastroenterology.

[2]  J. Pawlotsky,et al.  Dynamics of Hepatitis B Virus Resistance to Lamivudine , 2006, Journal of Virology.

[3]  Erwin Sablon,et al.  Advances in Molecular Diagnosis of HBV Infection and Drug Resistance , 2005, International journal of medical sciences.

[4]  K. Hu.  A Practical Approach to Management of Chronic Hepatitis B , 2005, International journal of medical sciences.

[5]  P. Cane,et al.  Quantitation of hepatitis B lamivudine resistant mutants by real-time amplification refractory mutation system PCR. , 2004, Journal of hepatology.

[6]  R. D. de Man,et al.  Identification of a new variant in the YMDD motif of the hepatitis B virus polymerase gene selected during lamivudine therapy. , 2002, Journal of medical microbiology.

[7]  Carl T Wittwer,et al.  Real-time PCR technology for cancer diagnostics. , 2002, Clinical chemistry.

[8]  N. Leung,et al.  Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: Results after 3 years of therapy , 2001, Hepatology.

[9]  M. Sata,et al.  Detection of YMDD motif mutations in some lamivudine-untreated asymptomatic hepatitis B virus carriers. , 2001, Journal of hepatology.

[10]  D. Pillay,et al.  Use of Real-Time PCR and Fluorimetry To Detect Lamivudine Resistance-Associated Mutations in Hepatitis B Virus , 1999, Antimicrobial Agents and Chemotherapy.

[11]  K. Walters,et al.  Identification and characterization of mutations in hepatitis B virus resistant to lamivudine , 1998 .